Charles Schwab Investment Management Inc Axogen, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 363,764 shares of AXGN stock, worth $5.69 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
363,764
Previous 335,105
8.55%
Holding current value
$5.69 Million
Previous $2.43 Million
110.18%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AXGN
# of Institutions
162Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$64 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$50.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$47 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$45.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$37.9 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $661M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...